arecor.com Report : Visit Site

Technical data of the arecor.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host arecor.com. Currently, hosted in Netherlands and its service provider is Digital Ocean Inc. .

the related websites

hl.co.uk oxfordtechnology.com housesigns.next.co.uk careers.next.co.uk stores.next.co.uk nextflowers.co.uk preview.next.co.uk cdn.next.co.uk vouchercodes.co.uk made2measure.next.co.uk itcareers.next.co.uk next2buy.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

you are using an outdated browser. please upgrade your browser to improve your experience. home about board of directors management scientific advisory board privacy policy products overview ultra-rapid acting insulin ultra-concentrated rapid acting insulin stable aqueous glucagon technology overview differentiated biosimilars with ip protection intravenous to subcutaneous switch lyophilised powder to liquid switch high concentration antibodies superior peptides thermostable therapeutics partnering technology proprietary products news and events news events contact us arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. arecor is leveraging this platform to (i) develop a portfolio of proprietary products for diabetes care and (ii) deliver superior reformulations of its partners proprietary products. scroll down watch our video proprietary product development arecor is committed to leveraging its arestat tm platform to develop a portfolio of proprietary products enabling improved treatment for diabetes care via the innovative reformulations of approved proteins and peptides. view our product overview technology partnering arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would simply not be possible using conventional formulation science. partner with us proprietary diabetes product development technology partnering proprietary diabetes product development what is diabetes? diabetes is a chronic condition that affects the body’s ability to control blood sugar level. if left untreated it can lead to serious health complications. download our fact sheet ultra-rapid acting insulin significantly faster onset of action improved glycemic control desired advancement for artificial pancreas view product stable aqueous glucagon no stable aqueous glucagon currently available ready to use pen to treat severe hypoglycemia critical unmet need for bi-hormonal artificial pancreas view product ultra-concentrated rapid acting insulin critical for miniaturisation of delivery devices superior fast acting insulin for high dose users view product technology partnering high concentration antibodies most biotherapeutic products in development are monoclonal antibodies or related… lyophilised powder to liquid switch there is a clear need within the pharmaceutical industry to… intravenous to subcutaneous switch there are a broad range of biotherapeutic products both on… differentiated biosimilars with ip protection the biosimilars market is a complex, highly competitive yet significant… superior peptides insulins & other diabetes peptides arecor is leveraging its unique… thermostable therapeutics most biotherapeutic products, particularly in liquid form, require refrigeration for… view our technology latest news and events 10th september 2018 press release – arecor secures £6m investment for the clinical development of its diabetes speciality pharma portfolio ↓ download pdf 8th august 2018 press release – arecor to give a short course and present at the bioprocessing summit, 13th-17th august 2018, sheraton boston, boston, ma, usa ↓ download pdf 2nd july 2018 patent portfolio update – arecor successfully defends a key european polysaccharide vaccine patent in its opposition proceedings ↓ download pdf 3rd - 4th january 2018 private: bio-europe spring, amsterdam, the netherlands bio-europe spring: amsterdam, the netherlands, 12-14 mar 2018 -- view event 8th - 11th january 2018 jp morgan healthcare conference, san francisco, us jp morgan healthcare conference, san francisco, us, 8 – 11 january 2018 -- view event 25th january 2018 london stock exchange: 4th annual future of healthcare investor forum our ceo, sarah howell shall be speaking at this event on 25 jan 2018. -- view event quick links diabetes products technology news careers contact privacy policy corporate fact sheet download corporate fact sheet follow us on website designed by carr kamasa design copyright arecor © 2018

URL analysis for arecor.com

http://arecor.com/technology/high-concentration-antibodies/
http://arecor.com/2018/
http://arecor.com/products/
http://arecor.com/technology/superior-peptides/
http://arecor.com/about-arecor/scientific-advisory-board/
http://arecor.com/products/ultra-concentrated-rapid-acting-insulin/
http://arecor.com/app/uploads/2018/09/arecor-secures-6.0m-investment-to-progress-its-lead-diabetes-programmes-into-clinical-trials-10092018-final_.pdf
http://arecor.com/technology/thermostable-therapeutics/
http://arecor.com/products/ultra-rapid-acting-insulin/
http://arecor.com/careers/
http://arecor.com/about-arecor/privacy-policy/
http://arecor.com/about-arecor/managment/
http://arecor.com/technology/
http://arecor.com/events/london-stock-exchange-3rd-annual-future-healthcare-investor-forum/
http://arecor.com/app/uploads/2018/07/arecor-technology-update_vaccines_29jun18_vf-web.pdf
carrkamasa.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: ARECOR.COM
Registry Domain ID: 114786260_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.it
Registrar URL: http://www.register.it
Updated Date: 2016-02-09T10:46:05Z
Creation Date: 2004-03-22T13:33:57Z
Registry Expiry Date: 2018-03-22T12:33:57Z
Registrar: Register.it SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +39.5520021555
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS0.PHASE8.NET
Name Server: NS1.PHASE8.NET
Name Server: NS2.PHASE8.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-01-17T15:28:15Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Register.it SPA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =arecor.com

  PORT 43

  TYPE domain

DOMAIN

  NAME arecor.com

  CHANGED 2016-02-09

  CREATED 2004-03-22

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS0.PHASE8.NET 81.88.63.114

  NS1.PHASE8.NET 85.233.160.68

  NS2.PHASE8.NET 85.233.164.62

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .